Treatments for Anxiety: Meditation and Escitalopram
Status:
Active, not recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
We propose the first randomized, controlled study to assess the comparative effectiveness of
Mindfulness-Based Stress Reduction (MBSR) with a medication for anxiety disorders. We will
use escitalopram, gold-standard SSRI treatment for patients with anxiety disorders, and will
examine the comparative effectiveness of the two treatments on anxiety symptoms and other
outcomes important to patients.